Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Di Rocco

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
The Lancet. Haematology|June 12, 2026
Real-world patient-reported symptomatic adverse events and concordance with physician assessments after CAR T-cell therapy in patients with aggressive B-cell lymphomas: a prospective studyFabio Efficace, Pier Luigi Zinzani, Francesca Bonifazi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2010
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patientsPier Luigi Zinzani, Giuseppe Rossi, Silvia Franceschetti, et al.
Hemasphere|February 20, 2020
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network StudyLucia Morello, Sara Rattotti, Laura Giordano, et al.
Blood|August 29, 2012
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS disseminationGiulia Benevolo, Alessandra Stacchini, Michele Spina, et al.
The Lancet. Haematology|February 22, 2017
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trialAndrés J M Ferreri, Marianna Sassone, Francesco Zaja, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 26, 2015
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)Salvatore Giacomo Morano, Roberto Latagliata, Corrado Girmenia, et al.
European Journal of Cancer Care|October 2, 2019
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI networkMariavita Ciccarone, Stefan Hohaus, Alessandro Pulsoni, et al.
Scientific Reports|December 11, 2021
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematologyGian Maria Zaccaria, Vito Colella, Simona Colucci, et al.
Blood Advances|August 5, 2025
Outcomes of CAR T-cells therapy in High-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysisAnna Dodero, Giusy Ceparano, Beatrice Casadei, et al.
Leukemia & Lymphoma|July 2, 2019
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network 'Rete Ematologica del Lazio per i Linfomi' (RELLI)Ombretta Annibali, Stefan Hohaus, Francesco Marchesi, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
The Lancet. Haematology|June 12, 2026
Real-world patient-reported symptomatic adverse events and concordance with physician assessments after CAR T-cell therapy in patients with aggressive B-cell lymphomas: a prospective studyFabio Efficace, Pier Luigi Zinzani, Francesca Bonifazi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2010
Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patientsPier Luigi Zinzani, Giuseppe Rossi, Silvia Franceschetti, et al.
Hemasphere|February 20, 2020
Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network StudyLucia Morello, Sara Rattotti, Laura Giordano, et al.
Blood|August 29, 2012
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS disseminationGiulia Benevolo, Alessandra Stacchini, Michele Spina, et al.
The Lancet. Haematology|February 22, 2017
Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trialAndrés J M Ferreri, Marianna Sassone, Francesco Zaja, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 26, 2015
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)Salvatore Giacomo Morano, Roberto Latagliata, Corrado Girmenia, et al.
European Journal of Cancer Care|October 2, 2019
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI networkMariavita Ciccarone, Stefan Hohaus, Alessandro Pulsoni, et al.
Scientific Reports|December 11, 2021
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematologyGian Maria Zaccaria, Vito Colella, Simona Colucci, et al.
Blood Advances|August 5, 2025
Outcomes of CAR T-cells therapy in High-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysisAnna Dodero, Giusy Ceparano, Beatrice Casadei, et al.
Leukemia & Lymphoma|July 2, 2019
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network 'Rete Ematologica del Lazio per i Linfomi' (RELLI)Ombretta Annibali, Stefan Hohaus, Francesco Marchesi, et al.
Pageof 11